Hong Kong Pharmaceuticals & Biotech High Growth Potential Companies

CARsgen Therapeutics Holdings

Market Cap: HK$10.6b

An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$101.8b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

Beijing Luzhu Biotechnology

Market Cap: HK$3.9b

A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China.

Guangzhou Innogen Pharmaceutical Group

Market Cap: HK$5.6b

Engages in the development of drugs.

Akeso

Market Cap: HK$110.7b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Keymed Biosciences

Market Cap: HK$19.5b

A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.

Cutia Therapeutics

Market Cap: HK$1.6b

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

XtalPi Holdings

Market Cap: HK$35.2b

Operates as a research platform company in Mainland China, the United States, and internationally.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$42.9b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Ocumension Therapeutics

Market Cap: HK$5.3b

Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.

Ascentage Pharma Group International

Market Cap: HK$14.5b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

Sihuan Pharmaceutical Holdings Group

Market Cap: HK$9.9b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China and the United States.

Everest Medicines

Market Cap: HK$11.3b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

InSilico Medicine Cayman TopCo

Market Cap: HK$30.3b

Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.

CanSino Biologics

Market Cap: HK$11.6b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

CStone Pharmaceuticals

Market Cap: HK$12.9b

A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.

Nanjing Leads Biolabs

Market Cap: HK$12.6b

A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.

GenFleet Therapeutics (Shanghai)

Market Cap: HK$13.2b

Operates as a biopharmaceutical company that focuses on developing novel treatment options in the fields of oncology that cover different lines of treatments of multiple solid tumors, as well as autoimmune and inflammatory diseases.

WuXi XDC Cayman

Market Cap: HK$69.1b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Mirxes Holding

Market Cap: HK$3.7b

A micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China.

Innovent Biologics

Market Cap: HK$142.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

SSY Group

Market Cap: HK$6.8b

An investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

Viva Biotech Holdings

Market Cap: HK$3.1b

An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.

China Medical System Holdings

Market Cap: HK$27.7b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Hua Medicine (Shanghai)

Market Cap: HK$3.6b

Engages in the development and commercialization of drugs for the treatment of diabetes in China.

China Traditional Chinese Medicine Holdings

Market Cap: HK$8.2b

China Traditional Chinese Medicine Holdings Co.

Consun Pharmaceutical Group

Market Cap: HK$12.6b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

Sino Biopharmaceutical

Market Cap: HK$96.2b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

RemeGen

Market Cap: HK$65.2b

A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.

Beijing Tong Ren Tang Chinese Medicine

Market Cap: HK$6.1b

Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.

WuXi Biologics (Cayman)

Market Cap: HK$139.4b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil.

Genscript Biotech

Market Cap: HK$30.8b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Shanghai Haohai Biological Technology

Market Cap: HK$8.8b

Shanghai Haohai Biological Technology Co., Ltd.

Grand Pharmaceutical Group

Market Cap: HK$20.7b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Simcere Pharmaceutical Group

Market Cap: HK$29.4b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.